Trials / Sponsors / Callisto Pharmaceuticals
Callisto Pharmaceuticals
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma Neuroendocrine Carcinoma | Phase 2 | 2007-11-01 |
| Terminated | Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia | Phase 1 | 2007-02-01 |
| Completed | Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinom Neuroendocrine Carcinoma | Phase 2 | 2006-10-01 |
| Unknown | Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia Acute Lymphocytic Leukemia | Phase 1 / Phase 2 | 2005-10-01 |
| Unknown | An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer Advanced Cancer | Phase 1 / Phase 2 | 2005-03-01 |
| Completed | Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2004-05-01 |